Skip to main content Accessibility help
  • Print publication year: 2014
  • Online publication date: February 2015

12 - Ultrasound imaging of uterine fibroids: evaluation and management

from Section 2 - Benign gynecology

Related content

Powered by UNSILO


1. Agdi M, Tulandi T. Minimally invasive approach for myomectomy. Semin Reprod Med 2010; 28(3):228–234.
2. Fasih N, Prasad Shanbhogue AK, Macdonald DB, et al. Leiomyomas beyond the uterus: unusual locations, rare manifestations. Radiographics 2008; 28(7): 1931–1948.
3. Evans P, Brunsell S. Uterine fibroid tumors: diagnosis and treatment. Am Fam Physician 2007; 75(10): 1503–1508.
4. Istre O. Management of symptomatic fibroids: conservative surgical treatment modalities other than abdominal or laparoscopic myomectomy. Best Pract Res Clin Obstet Gynaecol 2008; 22(4): 735–747.
5. Cooper NP, Okolo S. Fibroids in pregnancy – common but poorly understood. Obstet Gynecol Surv 2005; 60(2): 132–138.
6. Reed SD, Cushing-Haugen KL, Daling JR, et al. Postmenopausal estrogen and progestogen therapy and the risk of uterine leiomyomas. Menopause 2004; 11(2): 214–222.
7. King R, Overton C. Management of fibroids should be tailored to the patient. Practitioner 2011; 255(1738): 19–23, 2–3.
8. Cook H, Ezzati M, Segars JH, McCarthy K. The impact of uterine leiomyomas on reproductive outcomes. Minerva Ginecol 2010; 62(3): 225–236.
9. Bignardi T, Van den Bosch T, Condous G. Abnormal uterine and post-menopausal bleeding in the acute gynaecology unit. Best Pract Res Clin Obstet Gynaecol 2009; 23(5): 595–607.
10. Parker WH. Uterine myomas: management. Fertil Steril 2007; 88(2): 255–271.
11. Najeeb R, Awan AS, Bakhtiar U, Akhter S. Role of transvaginal sonography in assessment of abnormal uterine bleeding in perimenopausal age group. J Ayub Med Coll Abbottabad 2010; 22(1): 87–90.
12. Gojnic M, Pervulov M, Mostic T, Petkovic S. Doppler ultrasound as an additional parameter for the evaluation of myomas and the indication of myomectomy during pregnancy. Fetal Diagn Ther 2004; 19(5): 462–464.
13. Gervaise A. [Hierarchy for diagnostic and etiological management in menometrorrhagia].[Article in French]. J Gynecol Obstet Biol Reprod (Paris) 2008; 37(Suppl 8): S349–355.
14. Kroon B, Johnson N, Chapman M, et al; on behalf of the Australasian CREI Consensus Expert Panel on Trial evidence (ACCEPT) group. Fibroids in infertility – consensus statement from ACCEPT (Australasian CREI Consensus Expert Panel on Trial evidence). Aust N Z J Obstet Gynaecol 2011; 51(4): 289–295.
15. Imaoka I, Wada A, Matsuo M, et al. MR imaging of disorders associated with female infertility: use in diagnosis, treatment, and management. Radiographics 2003; 23(6): 1401–1421.
16. Fambrini M, Tondi F, Scarselli G, et al. Comparison of the number of uterine myomas detected by in-office transvaginal ultrasonography removed by laparotomic myomectomy: preoperative work-up concerns. Clin Exp Obstet Gynecol 2009; 36: 97–101.
17. Rajan DK, Margau R, Kroll RR, et al. Clinical utility of ultrasound versus magnetic resonance imaging for deciding to proceed with uterine artery embolization for presumed symptomatic fibroids. Clin Radiol 2011; 66(1): 57–62.
18. Spielmann AL, Keogh C, Forster BB, et al. Comparison of MRI and sonography in the preliminary evaluation for fibroid embolization. Am J Roentgenol 2006; 187(6): 1499–1504.
19. Moghadam R, Lathi RB, Shahmohamady B, et al. Predictive value of magnetic resonance imaging in differentiating between leiomyoma and adenomyosis. JSLS 2006; 10(2): 216–219.
20. Walker J. Transvaginal ultrasound guided biopsies in the diagnosis of pelvic lesions. Minim Invasive Ther Allied Technol 2003; 12(5): 241–244.
21. Estrade-Huchon S, Bouhanna P, Limot O, et al. Severe life-threatening hemoperitoneum from posttraumatic avulsion of a pedunculated uterine leiomyoma. J Minim Invasive Gynecol 2010; 17(5): 651–652.
22. Levy BS. Modern management of uterine fibroids. Acta Obstet Gynecol Scand 2008; 87(8): 812–823.
23. Kolankaya A, Arici A. Myomas and assisted reproductive technologies: when and how to act? Obstet Gynecol Clin North Am 2006; 33(1): 145–152.
24. Duhan N. Current and emerging treatments for uterine myoma – an update. Int J Womens Health 2011; 3: 231–241.
25. Purohit R, Sharma JG, Singh S. A case of diffuse uterine leiomyomatosis who had two successful pregnancies after medical management. Fertil Steril 2011; 95(7): 2434.e5–6.
26. Sayyah-Melli M, Tehrani-Gadim S, Dastranj-Tabrizi A, et al. Comparison of the effect of gonadotropin-releasing hormone agonist and dopamine receptor agonist on uterine myoma growth. Histologic, sonographic, and intra-operative changes. Saudi Med J 2009; 30(8): 1024–1033.
27. Wilkens J, Chwalisz K, Han C, et al. Effects of the selective progesterone receptor modulator asoprisnil on uterine artery blood flow, ovarian activity, and clinical symptoms in patients with uterine leiomyomata scheduled for hysterectomy. J Clin Endocrinol Metab 2008; 93(12): 4664–4671.
28. Tropeano G, Amoroso S, Scambia G. Non-surgical management of uterine fibroids. Hum Reprod Update 2008; 14(3): 259–274.
29. Venkatachalam S, Bagratee JS, Moodley J. Medical management of uterine fibroids with medroxyprogesterone acetate (Depo Provera): a pilot study. J Obstet Gynaecol 2004; 24(7): 798–800.
30. Suwandinata FS, Gruessner SE, Omwandho CO, Tinneberg HR. Pregnancy-preserving myomectomy: preliminary report on a new surgical technique. Eur J Contracept Reprod Health Care 2008; 13(3): 323–326.
31. Lee CL, Wang CJ. Laparoscopic myomectomy. Taiwan J Obstet Gynecol 2009; 48(4): 335–341.
32. Altgassen C, Kuss S, Berger U, et al. Complications in laparoscopic myomectomy. Surg Endosc 2006; 20(4): 614–618.
33. Falcone T, Bedaiwy MA. Minimally invasive management of uterine fibroids. Curr Opin Obstet Gynecol 2002; 14(4): 401–407.
34. Parker WH. Laparoscopic myomectomy and abdominal myomectomy. Clin Obstet Gynecol 2006; 49(4): 789–797.
35. Hanafi M. Predictors of leiomyoma recurrence after myomectomy. Obstet Gynecol 2005; 105(4): 877–881.
36. Simsek M, Sadik S, Taskin O, et al. Role of laparoscopic uterine artery coagulation in management of symptomatic myomas: a prospective study using ultrasound and magnetic resonance imaging. J Minim Invasive Gynecol 2006; 13(4): 315–319.
37. Akinola OI, Fabamwo AO, Ottun AT, Akinniyi OA. Uterine artery ligation for management of uterine fibroids. Int J Gynaecol Obstet 2005; 91(2): 137–140.
38. Liu WM, Tzeng CR, Yi-Jen C, Wang PH. Combining the uterine depletion procedure and myomectomy may be useful for treating symptomatic fibroids. Fertil Steril 2004; 82(1): 205–210.
39. Zupi E, Marconi D, Sbracia M, et al. Directed laparoscopic cryomyolysis for symptomatic leiomyomata: one-year follow up. J Minim Invasive Gynecol 2005; 12(4): 343–346.
40. Gupta JK, Sinha AS, Lumsden MA, Hickey M. Uterine artery embolization for symptomatic uterine fibroids. Cochrane Database Syst Rev 2006; 25(1): CD005073.
41. van der Kooij SM, Bipat S, Hehenkamp WJ, et al. Uterine artery embolization versus surgery in the treatment of symptomatic fibroids: a systematic review and meta-analysis. Am J Obstet Gynecol 2011; 205(4): 317.e1–18.
42. Stovall DW. Alternatives to hysterectomy: focus on global endometrial ablation, uterine fibroid embolization, and magnetic resonance-guided focused ultrasound. Menopause 2011; 18(4): 437–444.
43. Manyonda IT, Bratby M, Horst JS, et al. Uterine artery embolization versus myomectomy: impact on quality of life-results of the FUME (Fibroids of the Uterus: Myomectomy versus Embolization) trial. Cardiovasc Intervent Radiol 2012; 35(3): 530–536.
44. Ravina JH, Aymard A, Ciraru-Vigneron N, et al. [Uterine fibroids embolization: results about 454 cases].[Article in French] Gynecol Obstet Fertil 2003; 31(7–8): 597–605.
45. Poulsen B, Munk T, Ravn P. Long-term follow up after uterine artery embolization for symptomatic uterine leiomyomas. Acta Obstet Gynecol Scand 2011; 90(11): 1281–1283.
46. Ustünsöz B, Uğurel MS, Bozlar U, et al. Is uterine artery embolization prior to myomectomy for giant fibroids helpful? Diagn Interv Radiol 2007; 13(4): 210–212.
47. Chen WZ, Tang LD, Yang WW, et al. [Study on the efficacy and safety of ultrasound ablation in treatment of uterine fibroids.][Article in Chinese] Zhonghua Fu Chan Ke Za Zhi 2010; 45(12): 909–912.
48. Parthipun AA, Taylor J, Manyonda I, Belli AM. Does size really matter? Analysis of the effect of large fibroids and uterine volumes on complication rates of uterine artery embolisation. Cardiovasc Intervent Radiol 2010; 33(5): 955–959.
49. Recaldini C, Carrafiello G, Laganà D, et al. Percutaneous sonographically guided radiofrequency ablation of medium-sized fibroids: feasibility study. Am J Roentgenol 2007; 189(6): 1303–1306.
50. Guillot E, Omnes S, Yazbeck C, et al. [Endometrial ablation using hydrothermablator: results of a French multicenter study].[Article in French] Gynecol Obstet Fertil 2008; 36(1): 45–50.
51. Smart OC, Hindley JT, Regan L, Gedroyc WG. Gonadotrophin-releasing hormone and magnetic-resonance-guided ultrasound surgery for uterine leiomyomata. Obstet Gynecol 2006; 108(1): 49–54.
52. Jolesz FA. MRI-guided focused ultrasound surgery. Annu Rev Med 2009; 60: 417–430.
53. Rabinovici J, David M, Fukunishi H, et al; MRgFUS Study Group. Pregnancy outcome after magnetic resonance-guided focused ultrasound surgery (MRgFUS) for conservative treatment of uterine fibroids. Fertil Steril 2010; 93(1): 199–209.
54. Stewart EA, Gostout B, Rabinovici J, et al. Sustained relief of leiomyoma symptoms by using focused ultrasound surgery. Obstet Gynecol 2007; 110(2 Pt 1): 279–287.
55. Okada A, Morita Y, Fukunishi H, et al T. Non-invasive magnetic resonance-guided focused ultrasound treatment of uterine fibroids in a large Japanese population: impact of the learning curve on patient outcome. Ultrasound Obstet Gynecol 2009; 34(5): 579–583.
56. Taran FA, Tempany CM, Regan L, et al; MRgFUS Group. Magnetic resonance-guided focused ultrasound (MRgFUS) compared with abdominal hysterectomy for treatment of uterine leiomyomas. Ultrasound Obstet Gynecol 2009; 34(5): 572–578.
57. O’Sullivan AK, Thompson D, Chu P, et al. Cost-effectiveness of magnetic resonance guided focused ultrasound for the treatment of uterine fibroids. Int J Technol Assess Health Care 2009; 25(1): 14–25.
58. Behera MA, Leong M, Johnson L, Brown H. Eligibility and accessibility of magnetic resonance-guided focused ultrasound (MRgFUS) for the treatment of uterine leiomyomas. Fertil Steril 2010; 94(5): 1864–1868.
59. Cakmak , Akpınar IN, Yoldemir T, Cavdar S. Decreasing bleeding due to uterine fibroid with electroacupuncture. Fertil Steril 2011; 96(1): e13–15.
60. Rackow BW, Arici A. Fibroids and in-vitro fertilization: which comes first? Curr Opin Obstet Gynecol 2005; 17(3): 225–231.
61. Kolankaya A, Arici A. Myomas and assisted reproductive technologies: when and how to act? Obstet Gynecol Clin North Am 2006; 33(1): 145–152.
62. Klatsky PC, Tran ND, Caughey AB, Fujimoto VY. Fibroids and reproductive outcomes: a systematic literature review from conception to delivery. Am J Obstet Gynecol 2008; 198(4): 357–366.
63. Casini ML, Rossi F, Agostini R, Unfer V. Effects of the position of fibroids on fertility. Gynecol Endocrinol 2006; 22(2): 106–109.
64. Oliveira FG, Abdelmassih VG, Diamond MP, et al. Impact of subserosal and intramural uterine fibroids that do not distort the endometrial cavity on the outcome of in vitro fertilization-intracytoplasmic sperm injection. Fertil Steril 2004; 81(3): 582–587.